All In Biotech

Drug Trial Radar · NCT06516068

A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

A Multicenter, Randomized, Open-label Phase II Clinical Study on the Efficacy and Safety of HRS-1893 in Obstructive Hypertrophic Cardiomyopathy Subjects.

Last checked: Nov 20, 2026Latest source record: Jul 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

42

Actual

Start

Aug 11, 2024

Primary completion

Nov 18, 2024

Study completion Aug 2025

Sponsor

Sponsor type
Industry
First posted
Jul 23, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is being conducted to evaluate the efficacy, and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy

Conditions

  • Obstructive Hypertrophic Cardiomyopathy

Interventions

  • HRS-1893Drug

    HRS-1893

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The subjects' left ventricular outflow tract pressure gradient (Valsalva LVOT-G) was assessed for changes from the baseline after performing the Valsalva maneuverTime frame: After 12 weeks of HRS-1893 treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fuwai Hospital Chinese Academy of Medical Sciences (CAMS)

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.